title: Indian generics manufacturer Ranbaxy agrees to pay $500m to settle US fraud and drug safety charges.
authors.forename: Meera
authors.initials: M
authors.lastname: Kay
mesh_terms: D003257:Consumer Product Safety / Q000331:legislation & jurisprudence / Q000592:standards; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence / Q000592:standards; D016568:Drugs, Generic / Q000191:economics / Q000592:standards; D017850:Economics, Pharmaceutical; D005607:Fraud / Q000331:legislation & jurisprudence*; D006801:Humans; D007194:India; D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics / Q000592:standards
chemical_list: D016568:Drugs, Generic